© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 26, 2021
Subjective reader assessments performed best among several different parameters.
January 25, 2021
The treatment represents the first ever oral therapy approved by the FDA for lupus nephritis.
January 21, 2021
A related editorial noted the study authors’ numbers were higher than those of the Mayo Clinic.
January 20, 2021
About half of patients experienced adverse events, and two-thirds of those events were likely related to inflammatory bowel disease medications.
January 13, 2021
Researchers suggest bolstering beneficial gut species depleted in COVID-19 could mitigate severe disease.
It’s possible that C diff could be a marker for frailty in geriatric patients.
January 11, 2021
The negative effects of the pandemic may disrupt efforts to eradicate HBV as a public health threat by 2030.
January 09, 2021
Using piperacillin/tazobactam increases the risk for acute kidney injury, and this risk can be exacerbated by concurrent vancomycin.
January 07, 2021
New phase 3 data show the IL-23 inhibitor is associated with clinical remission and endoscopic response.
Anastomotic leak can increase morbidity, mortality, and length and cost of hospital stays.